Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of LINIPTIN vs Trajenta in healthy Thai volunteers
NCT06243809Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Apr 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by International Bio Service. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06243809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06243809.